Health System-Led Drug Company Unlikely to Make a Dent in Drug Prices, Shortages
As four not-for-profit health systems unveiled plans to create their own generic drug company Thursday, experts say they’ll face an uphill battle to make a significant dent in one of the fastest-growing industry expenses and persistent problems: rising drug prices and drug shortages.
